24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2026
2026 VC Survey
Boarding Pass
CTalk
BiblioTech
Corporate
Appointments
Tech Gateways
@Finance
Ctech Testimonials
Projects
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Divestment
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
Projects
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
21:21
Iranian missile strike and war delays at center of Tel Aviv luxury penthouse dispute
21:04
“NSO is behaving exactly like the dictators it serves”
20:44
Israel keeps Ben Gurion open under fire in bid to break Iran’s economic playbook
17:33
Pixellot: “There's no single word for what the past year has looked like operationally”
More stories
Buzz
Most popular
Daily
Weekly
1
AI startup fighting traffic fines faces shutdown by Israel’s bar association
2
A Security raises $37 million backed by Wiz CEO Assaf Rappaport and Cyera CEO Yotam Segev
3
Cyera raises $300 million at $12 billion valuation, extending its rapid ascent
4
Iron Dome and Iron Beam maker Rafael at center of Israeli government clash over IPO plan
5
Former unicorn Hailo cuts 50% of workforce amid funding pressure and strategic reset
More news
Divestment
8 stories about Divestment
Norwegian wealth fund divests from Israel’s banking sector
26.08.25
|
CTech
Four largest banks targeted for financing settlements; Caterpillar shares also sold.
Norway’s sovereign fund expands Israeli divestments amid Gaza war scrutiny
18.08.25
|
CTech, Reuters
Since late June, the fund has sold shares in 17 Israeli companies, including Paz, Azorim, Delek Motors, El Al, Energix, eToro, Max Stock, Levinsky Engineering, Priortech, Rami Levy, REIT 1, Retailors, Sela Real Estate, Amos Luzon Group Development and Energy, Firon, and Scope Metals.
With No Buyers, Teva to Close Israeli Medical Equipment Plant
09.04.18
|
Dror Reich
The facility in Ashdod is one of five Teva intends to sell or close in its home country
Allergan to Sell Teva Shares to J.P. Morgan
14.11.17
|
Dror Reich and Lilach Baumer
Allergan announced it pledged its 9.8% stake in Teva to J.P. Morgan as collateral, as part of a loan agreement. The company already agreed to sell a quarter of the stock in the first quarter of 2018
Teva Offloads Holdings in Australia’s Mesoblast
25.10.17
|
Dror Reich and Lilach Baumer
The stem-cell therapy company diluted Teva’s shares through a new offering in August
Founding Family Sells Holdings in Online Gambling Company 888
09.10.17
|
Golan Hazani and Lilach Baumer
Co-founder Aaron Shaked’s heirs sold their entire stake for nearly $300 million
Teva Sells Remaining Women's Health Assets
18.09.17
|
Lilach Baumer
After selling its Paragard business for $1.1 billion last week, Teva's remaining Women's Health business will be split between CVC Capital Partners and Foundation Consumer Healthcare in a $1.38 billion cash deal
Teva Negotiating Sale of Remaining Women's Health Assets, Report Says
14.09.17
|
Lilach Baumer
CVC Capital Partners is nearing a $800 million deal for Teva's remaining Women's Health business, Bloomberg reported Thursday